Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.

C4d Focal segmental glomerulosclerosis Immunohistochemistry Minimal change disease

Journal

Annals of diagnostic pathology
ISSN: 1532-8198
Titre abrégé: Ann Diagn Pathol
Pays: United States
ID NLM: 9800503

Informations de publication

Date de publication:
13 Feb 2024
Historique:
received: 23 01 2024
revised: 11 02 2024
accepted: 12 02 2024
medline: 29 2 2024
pubmed: 29 2 2024
entrez: 28 2 2024
Statut: aheadofprint

Résumé

C4d is an activation product of lectin pathway of complement. Glomerular deposition of C4d is associated with poor prognosis in different types of immune-related glomerulonephritis. The present study was conducted to investigate expression level of C4d and its staining pattern in renal biopsy of patients with focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) by immunohistochemistry method. In this retrospective cross-sectional study, renal biopsy specimens from 46 samples of MCD, 47 samples of FSGS, and 15 samples without glomerular disease as the controls, were subjected to immunohistochemistry staining with C4d. Demographic characteristics and information obtained from light and electron microscopy (EM) of patients were also extracted from their files. C4d positive staining was observed in 97.9 % of FSGS and 43.5 % of MCD samples, which showed a statistically significant difference (P < 0.001). The sensitivity and specificity of C4d expression for diagnosing FSGS were 97.9 % and 56.5 %, respectively. There was no significant correlation between C4d expression and any of the light and electron microscopy findings, including presence of foam cells, mesangial matrix expansion, interstitial fibrosis and tubular atrophy, and basement membrane changes in MCD patients. Also, no significant correlation was observed between C4d expression and clinical symptoms of proteinuria or prolonged high level of creatinine in patients with MCD. The expression of C4d marker had a good sensitivity and negative predictive value in the diagnosis of FSGS.

Identifiants

pubmed: 38417352
pii: S1092-9134(24)00018-2
doi: 10.1016/j.anndiagpath.2024.152281
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

152281

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests.

Auteurs

Maryam Abedi (M)

Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Fatemeh Nili (F)

Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Farshid Dehkhoda (F)

Department of Orthopedics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Alireza Abdollahi (A)

Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.

Samaneh Salarvand (S)

Department of Pathology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: sm.salarvand@gmail.com.

Classifications MeSH